Restless Leg Syndrome: Is There a Response to Buddhist Walking Meditation in Hemodialysis
Launched by CAIRO UNIVERSITY · Jan 29, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring whether Buddhist walking meditation can help relieve symptoms of Restless Leg Syndrome (RLS) in patients who are undergoing hemodialysis, a treatment for kidney failure. RLS is a common issue for these patients, causing uncomfortable sensations in the legs and an urge to move them. The study aims to see if practicing this form of meditation can improve their quality of life.
To participate in the trial, individuals must be hemodialysis patients who experience RLS and are not obese. Unfortunately, those with certain health issues, such as heart problems, lung diseases, mental health conditions, liver diseases, or injuries to the legs, cannot take part. Participants can expect to engage in Buddhist walking meditation and share their experiences. This study is still recruiting, so there’s an opportunity for interested patients to join and potentially benefit from this new approach to managing their symptoms.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • hemodialysis patient (40)
- • complain of restless leg syndrome
- • non obese patients
- Exclusion Criteria:
- • cardiac patients
- • chest diseases
- • mental diseases
- • hepatic diseases
- • lower limb orthopedic hurting
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Dokki, Giza, Egypt
Patients applied
Trial Officials
Ali MA Ismail, lecturer
Principal Investigator
Cairo University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported